AERIE PHARMACEUTICALS INC (AERI) Earnings History & Surprises

NASDAQ:AERI • US00771V1089

Current stock price

15.25 USD
+0.01 (+0.07%)
At close:
15.25 USD
0 (0%)
After Hours:

AERI Earnings overview

Past quarterly earnings results for AERIE PHARMACEUTICALS INC (AERI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Feb 22, 2023
Period
Q4 / 2022
EPS Estimate
-$0.44
Revenue Estimate
39.129M

Last Reported

Most Recent
Release Date
Nov 3, 2022
Period
Q3 / 2022
EPS Reported
-$0.27
EPS Surprise
39.47%
Revenue Surprise
-0.18%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2022 -0.27 -0.45 39.47% 62.50% 36.129M 36.195M -0.18% 23.25%
Q2 2022 -0.32 -0.57 44.16% 52.24% 33.311M 33.106M 0.62% 22.53%
Q1 2022 -0.66 -0.67 0.99% 8.33% 29.835M 30.466M -2.07% 29.89%
Q4 2021 1.09 -0.69 258.61% 237.97% 114.666M 32.083M 257.40% 364.61%
Q3 2021 -0.72 -0.63 -13.39% -10.77% 29.313M 29.473M -0.54% 45.98%
Q2 2021 -0.67 -0.66 -1.84% 19.28% 27.185M 26.653M 2.00% 50.78%
Q1 2021 -0.72 -0.69 -4.11% 13.25% 22.97M 23.121M -0.65% 12.93%
Q4 2020 -0.79 -0.75 -5.52% - 24.68M 22.809M 8.20% -
Q3 2020 -0.65 -0.82 20.44% - 20.08M 20.102M -0.11% -
Q2 2020 -0.83 -0.81 -2.28% - 18.03M 17.801M 1.29% -
Q1 2020 -0.83 -0.79 -5.00% - 20.34M 20.458M -0.58% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

AERI EPS Q2Q GrowthAERI EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 100 -100 200

Revenue Historical Q2Q growth and Acceleration

AERI Revenue Q2Q GrowthAERI Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 100 200 300

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
85.81%
Max EPS beat (4)
258.61%
Min EPS beat (4)
0.99%

Revenue beat statistics

Revenue beat (4)
2
Average Revenue beat (4)
63.94%
Max Revenue beat (4)
257.40%
Min Revenue beat (4)
-2.07%

Analysis

In the last 4 quarters, AERI has consistently beaten EPS estimates in all releases
AERI has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, AERI has beaten the EPS estimates by 85.8% on average.
In the last 4 quarters, AERI has beaten the revenue estimates by 63.9% on average.
AERI Overview AERI Technical Analysis Report AERI Fundamental Analysis Report AERI Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

AERIE PHARMACEUTICALS INC / AERI Earnings FAQ

What is the most recent earnings date for AERI stock?

AERIE PHARMACEUTICALS INC (AERI) last reported earnings on 11/3/2022.

Did AERIE PHARMACEUTICALS INC (AERI) beat earnings estimates last quarter?

AERIE PHARMACEUTICALS INC (AERI) beat EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often AERIE PHARMACEUTICALS INC beats earnings estimates?

In the last 4 quarters, AERIE PHARMACEUTICALS INC (AERI) has beaten EPS estimates in 4 out of 4 releases.